Type 2 diabetes is growing rapidly and is one of the world’s most prevalent chronic conditions. Weight-loss drugs, such as GLP-1s, will not eliminate the need for other tools people use to manage diabetes, such as continuous glucose monitoring (CGM) systems.
Data from a November analysis of people with Type 2 diabetes who were using GLP-1 medicines, yet still had an HbA1C level above 8 percent, saw a significant improvement in their HbA1C after adding FreeStyle Libre technology. In fact, adding FreeStyle Libre technology helped these patients improve their HbA1C more than GLP-1 therapy alone.   
 
             
             
             
             
            
Share